Navigation Links
Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY(R)
Date:12/11/2008

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Pain Therapeutics, Inc. and King Pharmaceuticals, Inc. disclaim any intent or obligation to update these forward-looking statements, and claim the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, any statements relating to the Companies' plan to discuss the Complete Response Letter with the FDA and provide an update when appropriate; the size and scope of the potential market for REMOXY and the potential benefits of REMOXY or the Companies' other drug candidates. Such statements are based on management's current expectations, but actual results may differ materially due to various factors. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to difficulties or delays in development, testing, regulatory approval, production and marketing of the Companies' drug candidates and unexpected adverse side-effects of the Companies' drug candidates and other factors that could slow or prevent product approval or market acceptance. For further information regarding these and other risks related to the Companies' business, investors should consult the Companies' respective filings with the U.S. Securities and Exchange Commission.


'/>"/>
SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
2. Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG
3. Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes
4. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints
5. Transition Therapeutics Announces Dates for Upcoming Corporate Events
6. Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer
7. Precision Therapeutics Secures $43 Million in Venture Capital Funding
8. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
9. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
10. Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
11. Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... The Deptford Center for Rehabilitation ... partnership designed to improve the quality of life ... (CHF) patients in the South Jersey area. Working ... team will help CHF patients manage their condition ... pairs the Cardiac Recovery program at the Deptford ...
(Date:11/26/2014)... November 26, 2014 German scientists say ... science can cause mesothelioma that looks and acts similar ... new article on the research. Click here to ... Institute for Toxicology and Experimental Medicine in Hannover injected ... all of the rats eventually developed mesothelioma , ...
(Date:11/26/2014)... 26, 2014 Loffler Companies has been ... in Imaging, an online information and news publication for ... the sixth consecutive year Loffler has earned this prestigious ... The Elite Dealer Awards honor the best and the ... Elite Dealer honorees were chosen for their innovative marketing ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance ... organization providing the adult demographic education and access ... navigate the rough seas of applying for Medicaid. Part ... the topic of Medicaid eligibility and proper planning, while ... applying for this coverage. , Senior Planning Services ...
(Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with ... sales(at)researchmoz(dot)us , Researchmoz.us announces a new research report ... deep study of the report on the diabetes topic ... The global glucose monitoring market has a growth rate ... diabetics in the world. Their numbers have prompted the ...
Breaking Medicine News(10 mins):Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3
... with material that was learned well, study suggests , , , ... can help boost your memory and remember facts, but only ... new study suggests. , This type of memory is called ... in contrast to "procedural memory," which applies to skills. Sleep ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... of $150 million of the Company,s common stock,through ... program. Any,remaining balance of the previously authorized program ... programs since November 2000,Perrigo has repurchased 11.4 million ...
... An anti-virus drug attacks influenza A by changing the motion ... to infect healthy cells, according to a recently published research ... Iowa States John D. Corbett Professor in Chemistry, and Sarah ... of the antiviral drug amantadine on influenza A. Thats the ...
... CDC Director Dr. Ann Albright, WASHINGTON, Feb. 1 , WHAT: ... briefing, "Your Eyes: the Windows to Your Health -- A Briefing ... Eyecare in Prevention," to be presented ... only one-third know they are living ...
... View of LTC Sector Required for Accurate Evaluation of,Seniors, ... on the January,31 New York Times news article reporting ... funding update to help care for the growing,number of ... Alliance for,Quality Nursing Home Care said it will work ...
... is imminent if Propofol coverage isn,t reinstated, NEW ... to,immediately retract its refusal to cover Propofol under all ... Gastroenterologists,and Anesthesiologist Alliance, a call to file a consumer ... once solely a New York State issue has now ...
Cached Medicine News:Health News:A Daytime Nap Can Boost Memory 2Health News:Iowa State chemists track how drug changes, blocks flu virus 2Health News:In Unfolding Budget Debate, Alliance to Spotlight Flawed MedPAC Policy Guidance, Failure to Evaluate Medicaid Margins in Recommending Medicare Funding Levels 2Health News:National Health Care Alliance Gains New Members Against Aetna's New Anesthesia Policy 2Health News:National Health Care Alliance Gains New Members Against Aetna's New Anesthesia Policy 3
(Date:11/26/2014)... Fla. , Nov. 25, 2014  Breckenridge ... into a multi-product ANDA agreement with Pii (Pharmaceutics ... ) under which Breckenridge and Pii expect to ... terms of the agreement, Pii will develop, manufacture ... and distribute the products under its own label.  ...
(Date:11/26/2014)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the ... conferences.  , 31 st NASDAQ Investor Program ... 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. Iain ... provide an overview of the company and a business and financial ... in New York, NY on Tuesday, December ...
(Date:11/26/2014)... Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Healthcare Conference in New York on ... . Dr. Helen Torley , President and Chief ... presentation will be webcast through the "Investors" section of Halozyme,s ... be made available for 90 days following the event. To ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... , ST. LOUIS, Dec. 22 KV Pharmaceutical Company ... Exchange (the "Exchange") for its securities to continue to trade on ... Annual Report on Form 10-K for the Company,s fiscal year ended ... the Company is unable to file the 2009 Annual Report on ...
... Dec. 22 On the morning of December 17, 2009, ... the center,s 10,000th patient, an 81-year-old male with a tumor deep ... impossible. Gamma Knife surgery is performed using Elekta,s Leksell Gamma Knife ... precisely on brain tumors and other targets in the head. ...
Cached Medicine Technology:KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 2KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 3KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 4KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 5KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 6KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010 7University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System 2University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System 3University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: